Penny stocks, which are deemed highly volatile, are shares of small companies that trade at a low price. They usually trade under $5 per share in the U.S. Penny biotech stocks, in particular, are typically early stage companies that specialize in drug development, medical devices, or cutting-edge therapies such as gene editing or immunotherapy. The majority of them do not yet have commercially available products.
However, a successful clinical trial or FDA approval can cause these stocks to skyrocket. Here are two penny biotech stocks that Wall Street is optimistic about.
